27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Alexander Aravanis, insider at Illumina

Alexander Aravanis Insider Information

SVP of Illumina
Alex Aravanis Ph.D. serves as Chief Technology Officer of the Company. Dr. Aravanis brings almost 20 years of experience in leading research and development efforts, spanning basic research and technology development through late stage clinical development, and is returning to Illumina from GRAIL, Inc. which he co-founded, and serves as the Chief Scientific Officer and Head of Research and Development. At GRAIL, he led the teams developing its multi-cancer early detection test by combining high-intensity sequencing approaches of unprecedented breadth and depth, and the latest tools of data science and data engineering, including powerful approaches from machine learning, such as neural networks. He and the GRAIL team created one of the largest clinical study programs ever in genomic medicine to support development of its products. Prior to GRAIL, Dr. Aravanis served in R&D for Illumina and developed multiple technologies, including clinical assays and bioinformatic pipelines for the analysis of RNA and DNA from fixed tissues, whole exome analysis, massively parallel single cell transcriptomics and liquid biopsy using cell-free nucleic acids. Dr. Aravanis holds a B.S. in Electrical Engineering, Computer Science, and Physics Minor from the University of California, Berkeley, as well as an M.S. and Ph.D. in Electrical Engineering, and an M.D. from Stanford University.

What is Alexander Aravanis' net worth?

The estimated net worth of Alexander Aravanis is at least $752,916.92 as of July 7th, 2022. Dr. Aravanis owns 3,346 shares of Illumina stock worth more than $752,917 as of August 10th. This net worth evaluation does not reflect any other investments that Dr. Aravanis may own. Additionally, Dr. Aravanis receives a salary of $1,050,000.00 as SVP at Illumina. Learn More about Alexander Aravanis' net worth.

How old is Alexander Aravanis?

Dr. Aravanis is currently 45 years old. There are 5 older executives and no younger executives at Illumina. Learn More on Alexander Aravanis' age.

What is Alexander Aravanis' salary?

As the SVP of Illumina, Inc., Dr. Aravanis earns $1,050,000.00 per year. Learn More on Alexander Aravanis' salary.

How do I contact Alexander Aravanis?

The corporate mailing address for Dr. Aravanis and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Alexander Aravanis' contact information.

Has Alexander Aravanis been buying or selling shares of Illumina?

During the past quarter, Alexander Aravanis has sold $107,800.00 of Illumina stock. Most recently, Alexander Aravanis sold 539 shares of the business's stock in a transaction on Thursday, July 7th. The shares were sold at an average price of $200.00, for a transaction totalling $107,800.00. Following the completion of the sale, the senior vice president now directly owns 3,346 shares of the company's stock, valued at $669,200. Learn More on Alexander Aravanis' trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 23 times. They sold a total of 22,130 shares worth more than $8,674,460.29. The most recent insider tranaction occured on July, 7th when SVP Alexander Aravanis sold 539 shares worth more than $107,800.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 7/7/2022.

Alexander Aravanis Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/7/2022Sell539$200.00$107,800.003,346View SEC Filing Icon  
11/12/2021Sell361$386.35$139,472.35View SEC Filing Icon  
11/2/2021Sell2,926$412.78$1,207,794.28View SEC Filing Icon  
10/26/2021Sell2,926$423.00$1,237,698.00View SEC Filing Icon  
10/19/2021Sell2,926$411.82$1,204,985.32View SEC Filing Icon  
10/12/2021Sell2,926$409.21$1,197,348.46View SEC Filing Icon  
7/7/2021Sell539$477.59$257,421.01View SEC Filing Icon  
See Full Table

Alexander Aravanis Buying and Selling Activity at Illumina

This chart shows Alexander Aravanis's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $227.30
Low: $220.36
High: $227.32

50 Day Range

MA: $203.00
Low: $177.23
High: $248.53

2 Week Range

Now: $227.30
Low: $173.45
High: $526.00


999,534 shs

Average Volume

1,144,228 shs

Market Capitalization

$35.71 billion

P/E Ratio


Dividend Yield



A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.